Silvia Maeso

Silvia Maeso is a seasoned professional in global market access, health economics, and pricing, currently serving as VP at Almirall since February 2023, where leadership includes driving global pricing strategies and ensuring access for medicines like Ebglyss. Previously, Maeso held the role of Vice President Global Market Access at Alira Health and spent over two decades at Almirall in various capacities, including Global Head of Market Access and Pricing, where notable achievements included securing positive HTA appraisals for Tildrakizumab and managing complex market access strategies. Academic credentials include a Master in Health Economics and Pharmacoeconomics from Universitat Pompeu Fabra and an Advanced Leadership Program from Esade, with ongoing studies in Business Administration at IESE Business School.